Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation

por Nada, Mohanad H., Wang, Hong, Workalemahu, Grefachew, Tanaka, Yoshimasa, Morita, Craig T.
Publicado 2017

PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancer

por Nada, Mohanad H., Wang, Hong, Hussein, Auter J., Tanaka, Yoshimasa, Morita, Craig T.
Publicado 2021

CD1-mediated γ/δ T Cell Maturation of Dendritic Cells

por Leslie, David S., Vincent, Michael S., Spada, Franca M., Das, Hiranmoy, Sugita, Masahiko, Morita, Craig T., Brenner, Michael B.
Publicado 2002

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug

por Tanaka, Yoshimasa, Iwasaki, Masashi, Murata-Hirai, Kaoru, Matsumoto, Kenji, Hayashi, Kosuke, Okamura, Haruki, Sugie, Tomoharu, Minato, Nagahiro, Morita, Craig T., Toi, Masakazu
Publicado 2017

Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells

por Okuno, Daisuke, Sugiura, Yuki, Sakamoto, Noriho, Tagod, Mohammed S. O., Iwasaki, Masashi, Noda, Shuto, Tamura, Akihiro, Senju, Hiroaki, Umeyama, Yasuhiro, Yamaguchi, Hiroyuki, Suematsu, Makoto, Morita, Craig T., Tanaka, Yoshimasa, Mukae, Hiroshi
Publicado 2020

Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug

por Tanaka, Yoshimasa, Murata‐Hirai, Kaoru, Iwasaki, Masashi, Matsumoto, Kenji, Hayashi, Kosuke, Kumagai, Asuka, Nada, Mohanad H., Wang, Hong, Kobayashi, Hirohito, Kamitakahara, Hiroshi, Okamura, Haruki, Sugie, Tomoharu, Minato, Nagahiro, Toi, Masakazu, Morita, Craig T.
Publicado 2018

Self-Recognition of Cd1 by γ/δ T Cells: Implications for Innate Immunity

por Spada, Franca M., Grant, Ethan P., Peters, Peter J., Sugita, Masahiko, Melián, Augustín, Leslie, David S., Lee, Hoi K., van Donselaar, Elly, Hanson, Dennis A., Krensky, Alan M., Majdic, Otto, Porcelli, Steven A., Morita, Craig T., Brenner, Michael B.
Publicado 2000